2007

     October     Mr. Gordon H. Busenbark Named as CFO
     March        First patient in phase II for XY2405
     January     Xytis begins Phase II for XY2405 in TBI
     January     Xytis announces $40 million NIH CRADA
     January     Dr. Vincent F. Simmon named President, CEO

2006
     January     Xytis merges and raises $24.5M

2005

     November  Xytis starts Phase I for XY2401 in SZ
     June         Xytis Licenses XY2405 from Fournier
     January     Xytis Licenses XY2401 from Rotta